Edition:
United States

Insider Trading: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

5,871JPY
8:33pm EDT
Change (% chg)

¥-2 (-0.03%)
Prev Close
¥5,873
Open
¥5,892
Day's High
¥5,894
Day's Low
¥5,871
Volume
70,500
Avg. Vol
699,008
52-wk High
¥7,280
52-wk Low
¥5,496

All Insider Trades

Institutional Holders

% Shares Owned: 45.60%
# of Holders: 253
Total Shares Held: 135,231,403
3 Mo. Net Change: 13,815,670
# New Positions: 11
# Closed Positions: 2
# Increased Positions: 61
# Reduced Positions: 22
# Net Buyers: 39

Officers & Directors

Name Age Since Current Position

Haruo Naito

69 2014 Chief Executive Officer, Representative Executive Officer, Director

Ryohei Yanagi

55 2015 Managing Executive Officer, Chief Financial Officer, Chief IR Officer

Hideki Hayashi

59 2016 Representative Executive Officer, Chief Information Officer

Junichi Asatani

56 2014 Chief Compliance Officer, Executive Officer

Kenta Takahashi

57 2016 General Counsel, Managing Executive Officer, President of Subsidiary

Ivan Cheung

40 2016 Managing Executive Officer, President of Neurology Business Group, President of America Region, Chairman & Chief Executive Officer of Subsidiary

Edward Geary

54 2013 Managing Executive Officer, Chief Medical Officer, Chief Director of Corporate Medical Affairs

Gary Hendler

50 2016 Managing Executive Officer, President of EMEA Region, Chief Commercial Officer of Oncology Business Group, President & Chief Executive Officer of Subsidiary

Terushige Iike

53 2016 Managing Executive Officer, President of Oncology Business Group

Masatomi Akana

50 2017 Executive Officer

Yanhui Feng

45 2016 Executive Officer, General Manager of Subsidiaries

Yasunobu Kai

55 2017 Executive Officer, Chief Planning Officer of Oncology Business Group, Director of Planning of Oncology Business Group

Shohei Kanazawa

52 2017 Executive Officer, President of Consumer hhc Business Unit

Hiroyuki Kato

59 2017 Executive Officer, Manager of Medicine Development Center

Yoshiteru Kato

57 2017 Executive Officer, President of Eisai Demand Chain Systems

Teiji Kimura

54 2016 Executive Officer, Chief Discovery Officer of Neurology Business Group, Director of Neurology Tsukuba Research Institute

Hiroyuki Kobayashi

43 2017 Executive Officer, Chief Medical Officer of Japan & Asia, Chief Director of Medical, Director of Neurology Medical Department

Lynn Kramer

66 2016 Executive Officer, Chief Clinical Officer of Neurology Business Group, Chief Medical Officer of Neurology Business Group

Masayuki Miyajima

55 2016 Executive Officer, President of Eisai Japan

Takashi Ohwa

54 2016 Executive Officer, Chief Medicine Creation Officer of Oncology Business Group, Chief Discovery Officer of Oncology Business Group

Shaji Procida

46 2014 Executive Officer, President of Subsidiary

Sayoko Sasaki

48 2017 Executive Officer, President of Asia Region

Alexander Scott

52 2016 Executive Officer, Chief Strategy Officer in Neurology Business Group, Director of Strategy in Neurology Business Group

Mitsuaki Tanaka

55 2017 Executive Officer, Chief Strategy Officer

Hidenori Yabune

47 2017 Executive Officer, Chief Director of Regional Cooperation Metropolitan Area of Eisai Japan

Tatsuyuki Yasuno

49 2017 Executive Officer, Chief Planning Officer, Director of Corporate Planning

Yasushi Okada

58 2017 Representative Executive Officer, Chief Talent Officer

Hirokazu Kanai

57 2016 Director

Noboru Naoe

61 2014 Director

Yutaka Tsuchiya

65 2017 Director

Bruce Aronson

65 2017 Independent Director

Tamaki Kakizaki

56 2016 Independent Director

Yasuhiko Kato

70 2016 Independent Director

Ikuo Nishikawa

66 2014 Independent Director

Eiichiro Suhara

69 2015 Independent Director

Daiken Tsunoda

50 2016 Independent Director

Toru Yamashita

69 2014 Independent Director

Shinya Watanabe

2016 Director of Accounting in Main Finance & Accounting Unit